tiprankstipranks
Trending News
More News >
Acumen Pharmaceuticals (ABOS)
NASDAQ:ABOS
US Market

Compare Acumen Pharmaceuticals (ABOS) vs. Competitors

Compare
551 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Acumen Pharmaceuticals
$1.98
$119.94M
-0.90
14.45%
5 Buy
0 Hold
0 Sell
Strong Buy
VistaGen Therapeutics
$0.64
$25.49M
-0.41
-78.28%
0 Buy
5 Hold
0 Sell
Hold
Inhibikase Therapeutics
$1.74
$211.00M
-3.05
-38.52%
5 Buy
0 Hold
0 Sell
Strong Buy
Surrozen
$19.60
$167.96M
-0.90
70.10%
3 Buy
0 Hold
0 Sell
Strong Buy
TScan Therapeutics
$1.14
$64.69M
-1.02
-55.47%
5 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ABOS
Acumen Pharmaceuticals
1.98
0.36
22.22%
VTGN
VistaGen Therapeutics
0.65
-2.24
-77.60%
ADVM
IKT
Inhibikase Therapeutics
1.74
-1.00
-36.50%
SRZN
Surrozen
19.60
8.37
74.64%
TCRX
TScan Therapeutics
1.14
-1.31
-53.47%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts